John Murphy, CEO The COVID-Long haul Foundation
Abstract
Since the emergence of SARS-CoV-2 in 2019, research has increasingly demonstrated that COVID-19 is a multisystem disease with significant ophthalmologic implications. While initially characterized as a respiratory illness, accumulating peer-reviewed evidence indicates that the virus affects the eye through direct infection, immune-mediated damage, vascular dysfunction, and neurological pathways. This article synthesizes current literature on ocular manifestations of COVID-19, ranging from mild conjunctivitis to severe retinovascular and neuro-ophthalmic complications, and evaluates long-term visual consequences associated with acute infection and “long COVID.” Particular attention is given to pathophysiological mechanisms, epidemiology, and emerging clinical patterns. The findings suggest that ocular involvement is both more prevalent and more complex than initially recognized, warranting long-term ophthalmologic surveillance.
1. Introduction
The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in profound global morbidity and mortality. Although early clinical attention focused on pulmonary pathology, subsequent research has revealed systemic involvement affecting cardiovascular, neurological, and ocular systems. Ophthalmologic manifestations were first noted early in the pandemic, particularly in the form of conjunctivitis, but have since expanded to include a broad spectrum of visual disturbances and structural eye disease.
Understanding COVID-19’s impact on vision is critical not only for patient care but also for elucidating viral pathophysiology, as the eye may serve both as a site of infection and a diagnostic window into systemic disease.
2. Mechanisms of Ocular Involvement
2.1 Viral Entry via Ocular Surface
SARS-CoV-2 gains cellular entry primarily through ACE2 receptors, which are expressed in conjunctival and corneal epithelial cells.
This provides a molecular basis for:
- Direct infection of ocular tissues
- Viral replication within the eye
- Potential transmission via tears and ocular secretions
The ocular surface is therefore both a portal of entry and a target organ.
2.2 Inflammatory and Immune-Mediated Injury
COVID-19 is associated with systemic inflammation and cytokine dysregulation (“cytokine storm”), which can extend to ocular tissues. This inflammatory cascade contributes to:
- Conjunctival inflammation
- Corneal nerve damage
- Retinal microvascular injury
Chronic inflammation is also implicated in persistent symptoms seen in long COVID.
2.3 Vascular and Thrombotic Effects
SARS-CoV-2 induces endothelial dysfunction and hypercoagulability, leading to:
- Retinal hemorrhages
- Vascular occlusions
- Microthrombi in ocular circulation
These mechanisms parallel systemic vascular complications and may result in vision-threatening pathology.
2.4 Neuro-Ophthalmic Pathways
The virus affects the central and peripheral nervous systems, including cranial nerves involved in eye movement and visual processing. Neuro-ophthalmic manifestations include:
- Diplopia (double vision)
- Cranial nerve palsies
- Optic neuritis
Recent studies indicate increased risk of diplopia and cranial nerve VI palsy compared to influenza.
3. Acute Ocular Manifestations
3.1 Conjunctivitis and Ocular Surface Disease
The most common ocular manifestation of COVID-19 is conjunctivitis (“pink eye”), often presenting with:
- Redness
- Tearing
- Irritation
Systematic reviews identify conjunctivitis as the most frequently reported symptom across studies.
Other ocular surface symptoms include:
- Dry eye
- Photophobia
- Burning sensation
These symptoms may occur early in infection and, in some cases, precede respiratory symptoms.
3.2 Prevalence of Ocular Symptoms
Reported prevalence varies widely:
- 2%–32% across studies
- Up to ~66% in some cohorts reporting at least one ocular symptom
Common symptoms include:
- Dryness (≈31.6%)
- Blurred vision (≈24.2%)
- Eye pain (≈21.5%)
These discrepancies likely reflect differences in study design and patient populations.
3.3 Visual Disturbances
Patients frequently report:
- Blurred vision
- Light sensitivity
- Difficulty focusing
Blurred vision has been observed in up to ~39% of patients in some studies and correlates with disease severity.
4. Retinal and Posterior Segment Involvement
4.1 Retinal Damage and Barrier Disruption
Emerging research shows that SARS-CoV-2 can breach the blood-retinal barrier, potentially leading to:
- Retinal inflammation
- Long-term visual impairment
4.2 Retinovascular Complications
Reported conditions include:
- Retinal vein occlusion
- Retinal artery occlusion
- Hemorrhages
These are likely mediated by systemic hypercoagulability and endothelial dysfunction.
4.3 Imaging Findings
Retinal imaging studies in long COVID patients reveal:
- Microvascular abnormalities
- Altered retinal thickness
These findings suggest that the retina may serve as a biomarker for systemic disease.
5. Neuro-Ophthalmic Complications
COVID-19 has been linked to a range of neurological eye disorders:
- Optic neuritis
- Uveitis
- Cranial nerve palsies
These conditions can lead to:
- Vision loss
- Eye movement abnormalities
- Persistent visual dysfunction
Although rare, such complications underscore the virus’s neuroinvasive potential.
6. Long COVID and Persistent Visual Symptoms
6.1 Chronic Ocular Symptoms
Long COVID patients frequently report:
- Dry eye syndrome
- Persistent blurred vision
- Photophobia
- Eye pain
Approximately 1 in 10 patients experience ongoing ocular issues after infection.
6.2 Corneal Nerve Damage
Studies have identified reduced corneal nerve fiber density in recovered patients, particularly those with long COVID.
This may explain:
- Chronic dryness
- Neuropathic eye pain
6.3 Functional Vision Changes
Patients report:
- Difficulty with depth perception
- Visual processing issues
These may reflect neurological rather than purely ocular damage.
7. Severity and Risk Factors
7.1 Association with Disease Severity
Ocular manifestations are often more severe in patients with:
- Severe COVID-19
- Systemic inflammation
- Comorbidities
Visual impairment correlates with overall disease severity.
7.2 Impact of Vaccination
Vaccination appears to reduce risk of certain ocular complications, including:
- Retinal edema
- Optic neuritis
8. Indirect Effects of the Pandemic on Eye Health
Beyond direct infection, the pandemic has influenced vision through:
- Increased screen time → digital eye strain
- Reduced access to eye care
- Lifestyle changes affecting ocular disease risk
Population studies suggest shifts in risk factors for conditions such as cataracts and macular degeneration.
9. Clinical Implications
9.1 Diagnosis and Monitoring
Clinicians should:
- Recognize ocular symptoms as potential COVID-19 indicators
- Monitor recovered patients for long-term visual changes
- Use retinal imaging where appropriate
9.2 Treatment Considerations
Management strategies include:
- Lubricating eye drops for dry eye
- Anti-inflammatory therapies
- Referral to specialists for neuro-ophthalmic symptoms
9.3 Public Health Considerations
The eye’s role as a transmission route underscores:
- Importance of eye protection in healthcare settings
- Need for awareness of ocular symptoms in screening
10. Future Research Directions
Key areas for further investigation include:
- Long-term retinal damage mechanisms
- Neuro-visual processing effects
- Impact of repeated infections
- Pediatric ocular outcomes
11. Conclusion
COVID-19 exerts a multifaceted impact on eyesight, ranging from mild, transient symptoms to severe, potentially vision-threatening conditions. The virus affects ocular health through direct infection, immune-mediated injury, vascular dysfunction, and neurological pathways. While many ocular manifestations resolve, a significant subset of patients experiences persistent visual symptoms, particularly in the context of long COVID.
The growing body of peer-reviewed evidence underscores the importance of integrating ophthalmologic evaluation into both acute and post-COVID care. As the pandemic evolves, continued research will be essential to fully elucidate the long-term implications for visual health.
Selected References (Footnote Style)
- Hu, K. et al. Ophthalmic Manifestations of Coronavirus (COVID-19). NCBI, 2024.
- SeyedAlinaghi, S.A. et al. Ocular manifestations of COVID-19: A systematic review. 2024.
- Lin, T.P.H. et al. COVID-19: Update on ocular involvement. 2021.
- Wang, S. et al. Ocular findings in COVID-19 patients. 2025.
- Azar, A.E. et al. Ophthalmic complications associated with COVID-19. 2025.
- Troisi, M. et al. Ocular sequelae in long COVID. 2025.
- MDPI Review: Impact of COVID-19 on ocular surface health.
- Nature/Frontiers studies on ocular prevalence and mechanisms.